Code Bio

0 followers


Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Employees

11-50

Links

Org chart

Brian P. McVeigh

Collapse
Dave Anderson
Chief Scientific Officer
Keith G. Dewedoff
Chief Financial Officer
Robert C. Getts
Chief Platform Technologies Officer
Alex T.
Chief Technical Officer
Lori A. Getts
Head of Process Development & Preclinical Production
Matthew Roberts
Head of Analytical Methods Development
Patricia Holt
Legal Affairs Lead
Paula Carpenter
Director, CMC Project Management at Code BioTherapeutics